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Abstract Myosin Is are associated with specific membranes,
however, the mechanism for regulating their intracellular
localization is unclear. As a first step towards understanding
this mechanism, membrane rebinding assays using Dictyostelium
myoB were performed. Crude, cytosolic myoB bound to intact,
but not to NaOH-treated plasma membranes. In contrast,
partially purified myoB binds to both intact and NaOH-treated
plasma membranes. Chemical cross-linking of cytosolic myoB
yielded several products, whereas none were found with the
partially purified myoB. These results suggest a model where
proteins regulating the specific binding of myoB to the plasma
membrane may exist both in the cytosol and on the plasma
membrane. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The class I myosins are ubiquitous and many cells express
more than one of these actin-based motor proteins. In lower
eukaryotes and fungi, these myosins play important roles in
endocytosis, secretion, polarization of the actin cytoskeleton,
and cell migration [1^4]. They have also been implicated in
endocytosis in mammalian cells where they have been found
to participate in various steps along the endocytic pathway
[5^7]. Class I myosins all share a conserved N-terminal motor
domain, a neck region that binds one^six low molecular
weight light chains, and a C-terminal tail region that has a
polybasic region that binds to membranes and actin ¢laments
with high a⁄nity [8,9]. There are several subclasses of myosin
I, as de¢ned by phylogenetic analyses [8]. The amoeboid sub-
class is the most widely expressed and it is distinguished from
other class I myosins by the presence of two additional C-
terminal tail domains ^ a region rich in glycine, proline, and
alanine (or serine or glutamate; GPA) that binds actin in an
ATP-independent manner and a src homology 3 domain
(SH3).
The existence of high a⁄nity binding sites for both actin (10
WM) and membranes (100 nM) in the tail of amoeboid myosin
Is suggests that the majority of this type of myosin I might be
associated with either the actin cytoskeleton or intracellular
membranes. Immunolocalization results are largely consistent
with this view, the vast majority of Acanthamoeba myosin IB
and IC are found in association with membranes [10], yeast
Myo3p is co-localized with actin patches and caps adjacent to
the plasma membrane [3], Aspergillus MYOA is enriched at
growing hyphal tips where membrane deposition occurs [1],
and Dictyostelium myoB and D are localized to the actin-rich
leading edge of migrating cells [11]. In contrast to these ¢nd-
ings, a recent analysis of the membrane association of several
Dictyostelium class I myosins (myoA, B, C and D) using a
cellular fractionation approach revealed that a substantial
amount of these, s 90%, are soluble (Senda et al., manuscript
submitted). Interestingly, this also appears to be the case with
Acanthamoeba myosin IA [12]. Additionally, the Dictyostelium
myosin Is (Senda et al., manuscript submitted), as well as
Acanthamoeba myosin IA [12] are exclusively associated with
the plasma membrane, in spite of apparently having the capa-
bility to bind to any membrane that exhibits a net negative
charge [13,14]. These results indicate that there must be a
mechanism for regulating the speci¢c membrane association
of a given myosin I, however, that mechanism remains to be
identi¢ed. An initial investigation into the membrane binding
abilities of cytosolic myosin I was undertaken in an e¡ort to
begin de¢ning the means by which its membrane association is
controlled.
2. Materials and methods
2.1. Preparation of membrane fractions
Dictyostelium plasma membranes (containing bound myoB), con-
tractile vacuoles, and lysosomal membrane were prepared as described
by others [15]. The TKMC bu¡er (20 mM TES (pH 7.5), 25 mM KCl,
5 mM MgCl2, 0.1 mM CaCl2) included 10 mM MgATP and a pro-
tease inhibitor cocktail (1 mM PMSF, 100 WM TPCK, 100 WM
TLCK, 10 Wg/ml chymostatin, 10 Wg/ml leupeptin, 10 Wg/ml antipain,
10 Wg/ml pepstatin and 10 WM 3,4-dichloroisocoumarin; Sigma Chem-
ical Co., St. Louis, MO, USA). This bu¡er is referred to throughout
as TKMC-ATP bu¡er. First, the cells were lysed and separated on a
sucrose step gradient into cytosolic and total membrane fractions
(Fig. 1). The total membrane was applied to a 30^70% sucrose gra-
dient in TKMC-ATP bu¡er and centrifuged at 100 000Ug in a linear
gradient to separate the various membrane compartments. Equal vol-
ume fractions were collected and an equal amount of each analyzed
for contractile vacuole marker enzyme activity (alkaline phosphatase)
and lysosomal marker enzyme activity (acid phosphatase) [16]. The
fractions were also analyzed by immunoblotting using chemilumines-
cent detection (Super Signal, Pierce Chemical Co., Rockford, IL,
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USA) for the presence of myoB using a rabbit polyclonal antibody
directed against Dictyostelium myoB tail region [17]. Previous results
have demonstrated that myoB co-fractionates with the plasma mem-
brane (Senda et al., manuscript submitted). The peak plasma mem-
brane, contractile vacuole, and lysosomal fractions were pooled.
Total plasma membrane lipids were extracted from using the pro-
cedure described by Bligh and Dyer [18]. Organic solvents were evapo-
rated by leaving samples in a chemical hood overnight. The dried
lipids were solubilized with 10% sodium cholate and the solution
dialyzed against several changes of 25 mM HEPES (pH 7.5), 150
mM NaCl, 1 mM MgCl2 and 0.1 mM EGTA until turbid. The dial-
ysate was sonicated by Micro Ultrasonic Cell Disruptor (Kontes,
Vineland, NJ, USA) on ice until the solution became clear. The lipid
vesicles were collected by centrifugation at 200 000Ug for 10 min,
resuspended with the rebinding bu¡er and immediately used for the
rebinding assay (described above). Quanti¢cation of phopholipids was
performed as described by Ames [19].
2.2. Partial puri¢cation of myoB
The progress of myoB puri¢cation was monitored throughout by
immunoblotting. Dictyostelium Ax-3 cells were developed in starva-
tion bu¡er for 4 h to increase the levels of membrane-associated myoB
(Senda et al., submitted). The cells were collected by centrifugation,
washed once with 50 mM HEPES (pH 7.5) and suspended with 50
mM HEPES (pH 7.5), 50 mM KCl, 1 mM MgCl2, 0.1 mM EGTA,
5 mM MgATP and 15% sucrose (¢nal concentrations). The cells were
lysed by passage through an N2 nebulizer (BioNeb Cell Disruptor,
GLAS-COL, Terre Haute, IN, USA) in the presence of protease in-
hibitor cocktail. The lysate was spun at 125 000Ug for 2 h and the
supernatant proteins were precipitated by the addition of solid am-
monium sulfate (AS) to 40%. The precipitant collected by centrifuga-
tion was resuspended to 25% AS (¢nal concentration) with 50 mM
HEPES (pH 7.5), 50 mM KCl, 2 mM MgCl2 and 5 mM MgATP. The
soluble fraction was obtained by ultracentrifugation at 200 000Ug for
2 h, loaded on Phenyl-650M column (TosoHaas, Montgomeryville,
PA, USA) and eluted with a step gradient of AS in 10 mM HEPES
(pH 7.5), 1 mM MgCl2, 0.1 mM EGTA and 0.1 mM MgATP. The
eluted myoB was pooled, precipitated by the addition of solid AS to a
¢nal concentration of 80% and collected by centrifugation. The myoB
pellet was dissolved in and dialyzed against 25 mM MES (pH 6.1),
50 mM NaCl, 1 mM MgCl2, 0.1 mM EGTA, 1 mM MgATP
(CM bu¡er) and 1 mM DTT for 3 h at 4‡C. The dialysate was
spun at 200 000Ug for 2 h in the presence of 5 mM MgATP
and the supernatant was loaded on Toyopearl CM-650M column
(TosoHaas) equilibrated with CM bu¡er. Proteins were eluted with
a linear gradient of NaCl in CM bu¡er and myoB-containing frac-
tions were pooled. The pooled fraction is referred to as partially
puri¢ed myoB.
2.3. Rebinding assay
The cytosolic fraction and partially puri¢ed myoB were dialyzed
against 20 mM PIPES (pH 7.0), 100 mM NaCl, 1 mM MgCl2 and
0.1 mM CaCl2 (rebinding bu¡er) for 6 h at 4‡C. The dialysate was
spun at 14 000Ug for 20 min after adjusting to 5 mM MgATP, 100
Wg/ml BSA and 1 mM DTT. The supernatants were carefully collected
and immediately used in rebinding studies. The plasma membrane
fraction was diluted with TKMC-ATP bu¡er and collected by centri-
fugation at 14 000Ug for 20 min. The plasma membranes were then
resuspended with TKMC-ATP bu¡er and the protein concentration
adjusted to 1 mg/ml. Half of the plasma membrane suspension was
treated with 100 mM NaOH (pHV11.0) for 1 min on ice to remove
peripheral proteins and the other half was untreated. Prior to the
rebinding assay, the various membrane fractions were pelleted by
centrifugation at 14 000Ug for 20 min and washed once with
TKMC-ATP bu¡er and once with the rebinding bu¡er. The mem-
branes were ¢nally resuspended with the rebinding bu¡er containing
5 mM MgATP, 100 Wg/ml BSA and 1 mM DTT. The total cytosol or
partially puri¢ed myoB were incubated with intact membrane or
NaOH-stripped membrane for 16 h at 4‡C with gentle agitation.
The mixtures were spun at 14 000Ug for 20 min. For the rebinding
assay with Dictyostelium lipids, partially puri¢ed myoB was incubated
with the lipids for 1 h at 22‡C and spun at 200 000Ug for 10 min. The
supernatants were carefully collected and precipitated by adding tri-
chloroacetic acid (TCA) to a ¢nal concentration of 5%. The TCA
precipitate and pelleted membranes were dissolved with an equal vol-
ume of SDS^PAGE sample bu¡er containing 6 M urea (USB) follow-
ing neutralization with ammonium bicarbonate. Equal volumes of the
supernatant and membrane pellet were analyzed by immunoblotting
for the presence of myoB.
Fig. 1. Crude myoB binds selectively to plasma membranes.
A: SDS^PAGE of total cytosol, enriched myoB and membranes.
Proteins present in the major fractions used in the rebinding experi-
ments are shown. Lane 1, total cytosol; lane 2, intact plasma mem-
brane; lane 3, NaOH-stripped plasma membrane; and lane 4,
partially puri¢ed myoB. The samples were electrophoresed on a
7.5% SDS^polyacrylamide gel stained with Coomassie blue (1, 2, 4)
or silver nitrate (3). The positions of known molecular standards (in
kDa) are indicated on the right. The presumptive myoB band is in-
dicated by an arrow in lane 4. The other prominent band in that
lane (at V135 kDa) is likely to be the myoC, a closely related Dic-
tyostelium amoeboid myosin I. B: Crude myoB binds to the plasma
membrane. Shown are the supernatants (S) and pellets (P) of re-
binding samples following overnight incubation, centrifugation and
immunoblotting of equal loadings of each sample for the myoB
heavy chain. Note that the myoB antibody only recognizes a single
band of 125 kDa. Total cytosol (C), intact plasma membrane (M)
and total cytosol plus intact plasma membranes (C+M). C: Crude
myoB does not bind to lysosomal membranes. Total cytosol (C), ly-
sosomal membranes (L) and total cytosol plus lysosomal membranes
(C+L). Note that because of the overlap between the plasma mem-
brane and lysosomal enzyme peaks, a small amount of myoB is
present in the lysosome fractions. D: Crude myoB does not bind to
contractile vacuole membranes. Total cytosol (C), contractile vacu-
ole membranes (CV) and total cytosol plus contractile vacuole mem-
branes (C+CV).
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2.4. Chemical cross-linking of myoB
The total cytosol and partially puri¢ed myoB were treated with 10
mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC, Sigma,
St. Louis, MO, USA) up to 20 min at room temperature. The reaction
was stopped by the addition of an equal volume of USB.
3. Results and discussion
The ability of cytosolic myoB (i.e. myoB present in the total
cytosol fraction) to bind to intact plasma membranes was ¢rst
examined. It should be noted that all rebinding experiments
were performed in the presence of MgATP to prevent the
association of myosin with membrane-associated actin via
the head domain. A total cytosol fraction (Fig. 1A, lane 1)
was incubated with puri¢ed membrane fractions (plasma
membrane, contractile vacuole, or lysosomes) and the samples
spun to separate the bound from unbound myoB following
overnight incubation in rebinding bu¡er. In the absence of
added membranes, all of the myoB present in the cytosol
fraction is in the supernatant (Fig. 1B). However, a small
amount of myoB was found in the pellet of the control mem-
brane sample as the plasma membrane contains bound myoB
(Fig. 1B; Senda et al., submitted). Incubation of the cytosol
with the intact plasma membrane (Fig. 1A, lane 2) fraction
resulted in a signi¢cant increase in the amount of membrane-
associated myoB (Fig. 1B). In contrast, no signi¢cant rebind-
ing of myoB to either contractile vacuole or lysosomal mem-
branes was observed when cytosol was incubated with either
of these fractions (Fig. 1C, D). These results demonstrate that
myoB present in the cytosol is capable of binding only to
isolated, intact plasma membrane. The myoB present in the
cytosol binds neither to contractile vacuole nor lysosomal
membranes, in spite of the relatively high content of acidic
phospholipids in these membranes [16]. Additionally, the in-
crease in the amount of membrane-associated myoB in the
plasma membrane fraction suggests that the isolated plasma
membranes have the capacity to bind more myosin I (i.e. their
myoB binding sites are not saturated). These results indicate
that there is speci¢city of membrane binding in vitro, as has
been observed in vivo.
Incubation of crude myoB with NaOH-stripped plasma
membranes, surprisingly, did not result in membrane binding
(Fig. 2A), in contrast to what is observed when intact mem-
branes are used (compare with Fig. 1B). These results sug-
gested that a peripheral membrane protein is required for
the binding of myoB to the plasma membrane. One obvious
candidate is a speci¢c myosin I receptor. However, previous
experiments employing puri¢ed Acanthamoeba myosin Is and
brush border myosin I (BBMI), that both contain a polybasic
domain adjacent to the motor domain, revealed that these
myosins are capable of high a⁄nity binding to NaOH-treated
biological membranes in vitro [13,14,20,21]. Since myoB also
contains a similar polybasic domain, the di¡erent membrane
binding properties of crude myoB could instead be attributed
to the association of some inhibitory protein. An enriched
Dictyostelium myoB fraction (Fig. 1, lane 4) was tested for
its ability to bind to the NaOH-stripped plasma membrane
fraction. The myoB present in the enriched fraction was capa-
ble of binding to intact plasma membranes, NaOH-stripped
plasma membranes, and extracted plasma membrane lipids
Fig. 2. Binding of myoB to the plasma membrane and extracted
plasma membrane lipids. Shown are the supernatants (S) and pellets
(P) of rebinding samples following overnight incubation, centrifuga-
tion and immunoblotting of equal loadings of each sample for the
myoB heavy chain. A: Crude myoB incubated with NaOH-stripped
plasma membranes. NaOH-stripped plasma membranes (N) do not
contain myoB and myoB present in the total cytosol does not bind
to the NaOH-stripped membrane (C+N). B: Partially puri¢ed myoB
incubated with intact plasma membranes. Partially puri¢ed myoB
(B) is soluble while myoB is present in the pellet of sedimented
intact plasma membrane (M) fraction. There is increased mem-
brane-associated myoB when partially puri¢ed myoB is incubated
with intact plasma membrane (B+M). C: Partially puri¢ed myoB
incubated with NaOH-stripped plasma membranes. Partially puri¢ed
myoB (B) is soluble and myoB is not present in NaOH-stripped
plasma membranes (N). Membrane-associated myoB results when
partially puri¢ed myoB is incubated with NaOH-stripped plasma
membranes (B+N). D: Partially puri¢ed myoB incubated with ex-
tracted plasma membrane lipids. Partially puri¢ed myoB (B) is solu-
ble but can bind to extracted plasma membrane lipids (B+Lp).
Fig. 3. Chemical cross-linking of myoB-containing fractions. The to-
tal cytosolic fraction (A) and the enriched myoB fraction (B) were
incubated with EDAC and the reaction terminated at the times indi-
cated in min. The samples were analyzed by immunoblotting for the
myoB heavy chain. The positions of known molecular weight stan-
dards are indicated on the left.
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(Fig. 2B, C, D). These results indicate that the puri¢cation
procedure employed to obtain an enriched fraction of myoB
removes the factor present in the cytosol that prevents myoB
from binding to NaOH-stripped membranes and that, as has
been reported for other amoeboid class I myosins [13,14],
myoB is capable of binding directly to lipids.
The potential association of cytosolic myoB with a protein
that might inhibit membrane binding was examined by per-
forming cross-linking of this fraction. The cytosol was incu-
bated for increasing lengths of time with EDAC, a zero-length
chemical cross-linker. Following a 20 min incubation with
EDAC, several higher molecular weight bands of 135, 140
and 150 kDa were observed when the samples were immuno-
blotted for myoB (Fig. 3A). Interestingly, when the partially
puri¢ed myoB was treated similarly, only a single 125 kDa
band was observed (Fig. 3B). This suggests that a protein(s) is
associated with cytosolic myoB, but not the partially puri¢ed
form. Since EDAC cross-links an amino residue directly to a
carboxyl residue, proteins that can be cross-linked by EDAC
must have close, speci¢c interactions. The cross-linking data
suggest that cytosolic myoB may form a speci¢c complex with
at least two small proteins (10 kDa and 15 kDa) and these
proteins may be readily detached from myoB during puri¢ca-
tion (Fig. 4). The size of the cross-linked products is consis-
tent with the likely size of a myoB light chain. The myoB
heavy chain does have a potential light chain binding site
[4], as is typical of most myosins. However, puri¢ed myoB
was not found to have an associated light chain [22]. If
myoB does have an associated light chain, then it might
have an extremely loose association with the myoB heavy
chain as it appears to be readily removed using two di¡erent
types of puri¢cation protocols [22]. This would be highly un-
usual for a non-calmodulin light chain, as those myosin light
chains appear to be tightly associated.
The results presented in this paper allow us to propose a
dual mechanism for regulating the membrane association of
Dictyostelium myoB in vivo (Fig. 4). We speculate that myoB
is prevented from binding to the stripped plasma membrane
by association with a cytosolic factor (CF). This could be a
low molecular weight protein molecule (Fig. 3A), possibly
even the myoB light chain itself. Given the high a⁄nity of
the myosin I polybasic domain for the plasma membrane
[13,14], it is likely that the CF binds to this region of myoB
tail in order to prevent its interaction with the plasma mem-
brane. Under appropriate conditions, myoB is capable of
binding to the target membrane (i.e. the plasma membrane)
only if a regulatory peripheral membrane protein is present.
The regulatory peripheral protein is unlikely to be a receptor
protein, based on the observation that myoB, as well as other
myosin Is [13,14,20,21], can bind directly to stripped mem-
branes and lipid vesicles (Fig. 2C, D). The regulatory protein
is likely to play a role in the release of myoB from the CF,
permitting the binding of the polybasic domain to the plasma
membrane. Lack of this membrane-associated regulatory fac-
tor in other cellular membranes, such as the contractile vacu-
ole or lysosomes, would prevent myosin I from binding to
these membranes and becoming non-speci¢cally distributed
throughout the cell. Thus, the dual mechanism proposed
here can account for the large proportion of observed soluble
myosin I in Dictyostelium and the speci¢city of myosin I mem-
brane binding in vivo.
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Fig. 4. A speculative model describing how myoB binding to the
plasma membrane is regulated. Cytosolic myoB associated with a
factor (CF) that inhibits its binding to membranes. Note that an ex-
cess of CF is postulated. Speci¢c membrane binding occurs when
the myoB/CF complex comes in contact with the plasma membrane
that contains a regulatory membrane protein (referred to here as
membrane factor, MF). Interaction of the CF with MF catalyzes
the release of the CF and permits binding of myoB to the plasma
membrane. If the myoB/CF complex comes into contact with mem-
branes lacking MF, such as those of a lysosome, it would not be
capable of binding to the membrane.
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